Page last updated: 2024-10-20

phosphorylethanolamine and Idiopathic Parkinson Disease

phosphorylethanolamine has been researched along with Idiopathic Parkinson Disease in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ross, BM1
Mamalias, N1
Moszczynska, A1
Rajput, AH1
Kish, SJ2
Rajput, A1
Gilbert, J1
Rozdilsky, B1
Chang, LJ1
Shannak, K1
Hornykiewicz, O1

Other Studies

2 other studies available for phosphorylethanolamine and Idiopathic Parkinson Disease

ArticleYear
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
    Neuroscience, 2001, Volume: 102, Issue:4

    Topics: Aged; Aged, 80 and over; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate

2001
Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
    Annals of neurology, 1986, Volume: 20, Issue:1

    Topics: Brain Chemistry; Corpus Striatum; Dopamine; Ethanolamines; gamma-Aminobutyric Acid; Glutamate Decarb

1986